203 related articles for article (PubMed ID: 30122833)
1. Changing Landscapes in the Neuroimaging of Dementia.
Ranganathan LN; Guhan R; Arun Shivaraman MM; Sankar PL; Srinivasan AV; Suriyakumar G; Periakaruppan AL
Ann Indian Acad Neurol; 2018; 21(2):98-106. PubMed ID: 30122833
[TBL] [Abstract][Full Text] [Related]
2. Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.
Neale N; Padilla C; Fonseca LM; Holland T; Zaman S
Neuroimage Clin; 2018; 17():263-271. PubMed ID: 29159043
[TBL] [Abstract][Full Text] [Related]
3. Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia.
Román G; Pascual B
Arch Med Res; 2012 Nov; 43(8):671-6. PubMed ID: 23142262
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
[TBL] [Abstract][Full Text] [Related]
5. Neuroimaging in dementia.
Whitwell JL; Jack CR
Neurol Clin; 2007 Aug; 25(3):843-57, viii. PubMed ID: 17659193
[TBL] [Abstract][Full Text] [Related]
6. Neuroimaging of Inflammation in Memory and Related Other Disorders (NIMROD) study protocol: a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses.
Bevan-Jones WR; Surendranathan A; Passamonti L; Vázquez Rodríguez P; Arnold R; Mak E; Su L; Coles JP; Fryer TD; Hong YT; Williams G; Aigbirhio F; Rowe JB; O'Brien JT
BMJ Open; 2017 Jan; 7(1):e013187. PubMed ID: 28064175
[TBL] [Abstract][Full Text] [Related]
7. Neuroimaging in Frontotemporal Lobar Degeneration: Research and Clinical Utility.
Dev SI; Dickerson BC; Touroutoglou A
Adv Exp Med Biol; 2021; 1281():93-112. PubMed ID: 33433871
[TBL] [Abstract][Full Text] [Related]
8. Neuroimaging in Pediatric Patients with Mild Traumatic Brain Injury: Relating the Current 2018 Centers for Disease Control Guideline and the Potential of Advanced Neuroimaging Modalities for Research and Clinical Biomarker Development.
Fong AK; Allen MD; Waltzman D; Sarmiento K; Yeates KO; Suskauer S; Wintermark M; Lindberg DM; Tate DF; Wilde EA; Loewen JL
J Neurotrauma; 2021 Jan; 38(1):44-52. PubMed ID: 32640874
[TBL] [Abstract][Full Text] [Related]
9. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
Saeed U; Lang AE; Masellis M
Front Neurol; 2020; 11():572976. PubMed ID: 33178113
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET in tau-negative amnestic dementia resembles that of autopsy-proven hippocampal sclerosis.
Botha H; Mantyh WG; Murray ME; Knopman DS; Przybelski SA; Wiste HJ; Graff-Radford J; Josephs KA; Schwarz CG; Kremers WK; Boeve BF; Petersen RC; Machulda MM; Parisi JE; Dickson DW; Lowe V; Jack CR; Jones DT
Brain; 2018 Apr; 141(4):1201-1217. PubMed ID: 29538658
[TBL] [Abstract][Full Text] [Related]
11. Dementia and neuroimaging.
Agosta F; Caso F; Filippi M
J Neurol; 2013 Feb; 260(2):685-91. PubMed ID: 23241895
[TBL] [Abstract][Full Text] [Related]
12. Clinical translation of neuroimaging research in mood disorders.
Konarski JZ; McIntyre RS; Soczynska JK; Bottas A; Kennedy SH
Psychiatry (Edgmont); 2006 Feb; 3(2):46-57. PubMed ID: 21103155
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging in Parkinsonian Disorders.
Tripathi M; Kumar A; Bal C
Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
[TBL] [Abstract][Full Text] [Related]
14. Clinical neuroimaging in psychiatry.
Rauch SL; Renshaw PF
Harv Rev Psychiatry; 1995; 2(6):297-312. PubMed ID: 9384916
[TBL] [Abstract][Full Text] [Related]
15. Database of normal human cerebral blood flow measured by SPECT: I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry.
Ito H; Inoue K; Goto R; Kinomura S; Taki Y; Okada K; Sato K; Sato T; Kanno I; Fukuda H
Ann Nucl Med; 2006 Feb; 20(2):131-8. PubMed ID: 16615422
[TBL] [Abstract][Full Text] [Related]
16. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
Atri A
Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
[TBL] [Abstract][Full Text] [Related]
17. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity.
Val-Laillet D; Aarts E; Weber B; Ferrari M; Quaresima V; Stoeckel LE; Alonso-Alonso M; Audette M; Malbert CH; Stice E
Neuroimage Clin; 2015; 8():1-31. PubMed ID: 26110109
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's Dementia: The Emerging Role of Positron Emission Tomography.
Tripathi SM; Murray AD
Neuroscientist; 2022 Oct; 28(5):507-519. PubMed ID: 33660556
[TBL] [Abstract][Full Text] [Related]
19. Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies.
Sarro L; Senjem ML; Lundt ES; Przybelski SA; Lesnick TG; Graff-Radford J; Boeve BF; Lowe VJ; Ferman TJ; Knopman DS; Comi G; Filippi M; Petersen RC; Jack CR; Kantarci K
Brain; 2016 Oct; 139(Pt 10):2740-2750. PubMed ID: 27452602
[TBL] [Abstract][Full Text] [Related]
20. What can imaging tell us about cognitive impairment and dementia?
Narayanan L; Murray AD
World J Radiol; 2016 Mar; 8(3):240-54. PubMed ID: 27029053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
